Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (18)

2023

  1. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

2021

  1. Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain

    Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941

  2. Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain

    British Journal of Pharmacology, Vol. 178, Núm. 20, pp. 4176-4192

  3. Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo

    GLIA, Vol. 69, Núm. 3, pp. 532-545

2020

  1. Cannabinoid-induced motor dysfunction via autophagy inhibition

    Autophagy, Vol. 16, Núm. 12, pp. 2289-2291

  2. Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB1 receptors

    Development (Cambridge, England), Vol. 147, Núm. 24

  3. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure

    Neuropsychopharmacology, Vol. 45, Núm. 5, pp. 877-886

  4. Possible therapeutic applications of cannabis in the neuropsychopharmacology field

    European Neuropsychopharmacology, Vol. 36, pp. 217-234

2019

  1. Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia

    Frontiers in Pharmacology, Vol. 9, Núm. JAN

  2. Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration

    Translational Neurodegeneration, Vol. 8, Núm. 1

2018

  1. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders

    Biochemical Pharmacology, Vol. 157, pp. 85-96

2017

  1. Loss of Cannabinoid CB1 Receptors Induces Cortical Migration Malformations and Increases Seizure Susceptibility

    Cerebral Cortex, Vol. 27, Núm. 11, pp. 5303-5317

2016

  1. A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease

    Journal of Neurology, Vol. 263, Núm. 7, pp. 1390-1400

  2. VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease

    Scientific Reports, Vol. 6

2013

  1. Cannabinoids, neurogenesis and antidepressant drugs: Is there a link?

    Current Neuropharmacology, Vol. 11, Núm. 3, pp. 263-275

2012

  1. The CB1 cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis

    Journal of Neuroscience, Vol. 32, Núm. 47, pp. 16651-16665

2009

  1. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

    Brain, Vol. 132, Núm. 11, pp. 3152-3164